SCHEMBL6397241

SCHEMBL6397241

CC(c1ccc(O)cc1)C(O)c1ccc(O)cc1P(=O)(O)O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 4/20 0.36
ESR2 Q92731 4/20 0.36
PDCD1 Q15116 1/20 0.36
CD274 Q9NZQ7 1/20 0.36
TYR P14679 1/20 0.34
ADRB1 P08588 2/20 0.32
ADRA1A P35348 2/20 0.32
MIF P14174 1/20 0.32
HTR2A P28223 1/20 0.32
HTR2B P41595 1/20 0.32
GRM8 O00222 1/20 0.31
GRM4 Q14833 1/20 0.31
ADRB2 P07550 2/20 0.31
LMNA P02545 2/20 0.31
HIF1A Q16665 2/20 0.31
SLC6A2 P23975 2/20 0.31
SLC6A4 P31645 2/20 0.31
OPRM1 P35372 2/20 0.31
CYP2D6 P10635 1/20 0.31
GALR3 O60755 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6399069 0.88 ESR1 (0.36) ESR1ESR2PDCD1CD274TYR
SCHEMBL6402426 0.87 ADRB1 (0.45) ESR1ESR2TYRADRB1ADRA1A
SCHEMBL6398725 0.81 ESR1 (0.49) ESR1ESR2TYRADRA1AGRM8
SCHEMBL6395717 0.79 ESR1 (0.34) ESR1ESR2PDCD1CD274ADRB1
SCHEMBL6401108 0.78 ESR1 (0.38) ESR1ESR2PDCD1CD274TYR
SCHEMBL6398002 0.78 INPPL1 (0.37) ESR1ESR2PDCD1CD274TYR
SCHEMBL6397232 0.78 ESR1 (0.33) ESR1ESR2PDCD1CD274TYR
SCHEMBL6397799 0.75 INPPL1 (0.38) ESR1ESR2PDCD1CD274LMNA
SCHEMBL6399062 0.75 ESR1 (0.33) ESR1ESR2PDCD1CD274
SCHEMBL6395103 0.75 ADRB1 (0.45) ESR1ESR2TYRADRB1ADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050187195-A1 Inhibition of intestinal apical membrane Na/phosphate co-transportation in humans PEERCE BRIAN E (US) 2005-08-25 US disclosed
US-20030162753-A1 Inhibition of intestinal apical membrane Na/phosphate co-transportation in humans BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2003-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050187195-A1 Inhibition of intestinal apical membrane Na/phosphate co-transportation in humans SLC34A3, SLC34A1, SLC34A2 ESR1 2885/4885ESR2 2416/4885PDCD1 2817/4885
US-20030162753-A1 Inhibition of intestinal apical membrane Na/phosphate co-transportation in humans SLC34A3, SLC34A1, SLC34A2 ESR1 2885/4885ESR2 2416/4885PDCD1 2817/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.